Related Experiment Video
Updated: May 19, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Pulse pressure and mild cognitive impairment
Teodora Yaneva-Sirakova1, Rumiana Tarnovska-Kadreva, Latchezar Traykov
1Cardiology Clinic, University Hospital 'Alexandrovska' Sofia, Bulgaria. teodora.yaneva@gmail.com
Insights
Elevated pulse pressure (PP), a measure of blood pressure, is linked to cognitive impairment in patients with hypertension. This finding highlights PP as an important indicator of cardiovascular risk and target organ damage.
Area of Science:
- Cardiology
- Neurology
- Gerontology
Background:
- Suboptimal blood pressure (BP) control increases cardiovascular risk and risk for cognitive impairment.
- Pulse pressure (PP) is an underestimated risk factor for target organ damage, assessed via ambulatory BP monitoring (ABPM) or self-measurement.
Purpose of the Study:
- To investigate the correlation between pulse pressure and cognitive function in hypertensive patients.
- To determine if elevated PP is a predictor of cognitive impairment.
Main Methods:
- 148 hypertensive patients (mean age 64.16 years) underwent medical history, physical examination, lab screening, and ABPM.
- Neuropsychological tests (Mini Mental State Examination and Montreal Cognitive Assessment) assessed cognitive function.
Main Results:
- Regression analysis revealed a correlation between day/night PP and neuropsychological test results.
- Significant differences in cognitive test scores were observed between groups with PP >50 mmHg and ≤50 mmHg (P=0.02 for MMSE).
- Daytime PP (P=0.01) and nighttime PP (P=0.02) differed significantly between patients with and without cognitive impairment.
Conclusions:
- Elevated PP, day or night, correlates with cognitive impairment in hypertensive individuals.
- PP serves as a marker for large artery stiffness and target organ damage, even in younger hypertensive patients.
Objective:
Patients with suboptimal blood pressure (BP) control may remain with an elevated cardiovascular risk and risk for cognitive impairment. Pulse pressure (PP) assessed with ambulatory BP monitoring (ABPM) or self-measurement so far has been an underestimated risk factor for target organ damage.
Methods:
One hundred and forty-eight patients were screened: 51 men (34.5%) and 97 women (65.5%), mean age 64.16 ± 11.18 years and a mean hypertension history of 13.1 ± 11.05 years. We gathered full medical and hypertension history, physical examination, laboratory screening and ambulatory blood pressure monitoring. Neuropsychological profile was assessed with tests (NPTs): Mini Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA).
Results:
Regression analysis found a correlation between day and night PP and NPT results. Mann-Whitney Test (α less than 0.05) was used to find a significant difference (P = 0.02 for MMSE) in the mean values of the NPT results between the groups with PP more than 50 and PP 50 mmHg or less. The result was not age dependent. There was also a significant difference between mean values of day-PP (P = 0.01) and night-PP (P = 0.02) between patients with cognitive impairment and those without (respectively more than 55 mmHg and less than 55 mmHg).
Conclusion:
Elevated PP during the day, the night or with self-measurement is correlated with cognitive impairment. It is a marker of large artery stiffness and target organ damage not only in the very elderly, but also in younger individuals (mean age 64.16 years).
Related Concept Videos
Blood Pressure
Measurement of Blood Pressure
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...
Pulse amplitude and quality
A weak or absent pulse may indicate reduced cardiac output or poor left ventricular contraction, which can be signs of cardiovascular dysfunction or...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Dementia l: Introduction
